nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—TYMS—Methotrexate—ankylosing spondylitis	0.465	0.91	CbGbCtD
Capecitabine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0458	0.0897	CbGbCtD
Capecitabine—TYMS—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	0.000493	0.0331	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Methylprednisolone—ankylosing spondylitis	0.000486	0.0327	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	0.000485	0.0326	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Betamethasone—ankylosing spondylitis	0.000485	0.0326	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Methylprednisolone—ankylosing spondylitis	0.000481	0.0324	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Betamethasone—ankylosing spondylitis	0.000479	0.0322	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Dexamethasone—ankylosing spondylitis	0.000479	0.0322	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	0.000474	0.0319	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Betamethasone—ankylosing spondylitis	0.000474	0.0319	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Dexamethasone—ankylosing spondylitis	0.000474	0.0319	CbGdCrCtD
Capecitabine—TYMS—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000469	0.0316	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Triamcinolone—ankylosing spondylitis	0.000468	0.0315	CbGdCrCtD
Capecitabine—TYMS—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000462	0.0311	CbGdCrCtD
Capecitabine—TYMS—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000462	0.0311	CbGdCrCtD
Capecitabine—TYMS—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000451	0.0304	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Prednisone—ankylosing spondylitis	0.00045	0.0302	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Prednisone—ankylosing spondylitis	0.000444	0.0299	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.000444	0.0298	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Prednisone—ankylosing spondylitis	0.000439	0.0295	CbGdCrCtD
Capecitabine—TYMS—Clobetasol propionate—Prednisolone—ankylosing spondylitis	0.000439	0.0295	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Dexamethasone—ankylosing spondylitis	0.000437	0.0294	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Betamethasone—ankylosing spondylitis	0.000437	0.0294	CbGdCrCtD
Capecitabine—TYMS—Flunisolide—Prednisolone—ankylosing spondylitis	0.000433	0.0291	CbGdCrCtD
Capecitabine—TYMS—Triamcinolone—Prednisolone—ankylosing spondylitis	0.000429	0.0288	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Triamcinolone—ankylosing spondylitis	0.000427	0.0287	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Prednisone—ankylosing spondylitis	0.000405	0.0272	CbGdCrCtD
Capecitabine—TYMS—Diflorasone—Prednisolone—ankylosing spondylitis	0.000395	0.0266	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Methylprednisolone—ankylosing spondylitis	0.000389	0.0262	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Betamethasone—ankylosing spondylitis	0.000383	0.0257	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Dexamethasone—ankylosing spondylitis	0.000383	0.0257	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Triamcinolone—ankylosing spondylitis	0.000374	0.0252	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Prednisone—ankylosing spondylitis	0.000355	0.0239	CbGdCrCtD
Capecitabine—TYMS—Budesonide—Prednisolone—ankylosing spondylitis	0.000346	0.0233	CbGdCrCtD
Capecitabine—TYMS—Danazol—Prednisone—ankylosing spondylitis	0.00034	0.0229	CbGdCrCtD
Capecitabine—Syncope—Betamethasone—ankylosing spondylitis	0.000337	0.000711	CcSEcCtD
Capecitabine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000336	0.000708	CcSEcCtD
Capecitabine—Infection—Triamcinolone—ankylosing spondylitis	0.000336	0.000708	CcSEcCtD
Capecitabine—Infection—Methylprednisolone—ankylosing spondylitis	0.000336	0.000707	CcSEcCtD
Capecitabine—Haematuria—Methotrexate—ankylosing spondylitis	0.000334	0.000704	CcSEcCtD
Capecitabine—Shock—Triamcinolone—ankylosing spondylitis	0.000333	0.000702	CcSEcCtD
Capecitabine—Insomnia—Prednisolone—ankylosing spondylitis	0.000333	0.000701	CcSEcCtD
Capecitabine—Alopecia—Prednisone—ankylosing spondylitis	0.000333	0.000701	CcSEcCtD
Capecitabine—Shock—Methylprednisolone—ankylosing spondylitis	0.000332	0.0007	CcSEcCtD
Capecitabine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000331	0.000698	CcSEcCtD
Capecitabine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000331	0.000698	CcSEcCtD
Capecitabine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000331	0.000697	CcSEcCtD
Capecitabine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000331	0.000697	CcSEcCtD
Capecitabine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000331	0.000696	CcSEcCtD
Capecitabine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00033	0.000696	CcSEcCtD
Capecitabine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00033	0.000696	CcSEcCtD
Capecitabine—Mental disorder—Prednisone—ankylosing spondylitis	0.00033	0.000695	CcSEcCtD
Capecitabine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00033	0.000694	CcSEcCtD
Capecitabine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000328	0.000691	CcSEcCtD
Capecitabine—Erythema—Prednisone—ankylosing spondylitis	0.000328	0.00069	CcSEcCtD
Capecitabine—Malnutrition—Prednisone—ankylosing spondylitis	0.000328	0.00069	CcSEcCtD
Capecitabine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000327	0.000689	CcSEcCtD
Capecitabine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000327	0.000689	CcSEcCtD
Capecitabine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000326	0.000688	CcSEcCtD
Capecitabine—Hypertension—Betamethasone—ankylosing spondylitis	0.000325	0.000684	CcSEcCtD
Capecitabine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000325	0.000684	CcSEcCtD
Capecitabine—Myalgia—Betamethasone—ankylosing spondylitis	0.00032	0.000675	CcSEcCtD
Capecitabine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00032	0.000675	CcSEcCtD
Capecitabine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000319	0.000673	CcSEcCtD
Capecitabine—Anxiety—Betamethasone—ankylosing spondylitis	0.000319	0.000673	CcSEcCtD
Capecitabine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000317	0.000667	CcSEcCtD
Capecitabine—Discomfort—Betamethasone—ankylosing spondylitis	0.000317	0.000667	CcSEcCtD
Capecitabine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000316	0.000666	CcSEcCtD
Capecitabine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000316	0.000665	CcSEcCtD
Capecitabine—Pain—Prednisolone—ankylosing spondylitis	0.000315	0.000663	CcSEcCtD
Capecitabine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000315	0.000663	CcSEcCtD
Capecitabine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000315	0.000663	CcSEcCtD
Capecitabine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000312	0.000658	CcSEcCtD
Capecitabine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000311	0.000655	CcSEcCtD
Capecitabine—Vision blurred—Prednisone—ankylosing spondylitis	0.000309	0.000651	CcSEcCtD
Capecitabine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000308	0.00065	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000308	0.00065	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000308	0.000648	CcSEcCtD
Capecitabine—Oedema—Betamethasone—ankylosing spondylitis	0.000307	0.000647	CcSEcCtD
Capecitabine—Oedema—Dexamethasone—ankylosing spondylitis	0.000307	0.000647	CcSEcCtD
Capecitabine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000306	0.000645	CcSEcCtD
Capecitabine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000305	0.000643	CcSEcCtD
Capecitabine—Infection—Dexamethasone—ankylosing spondylitis	0.000305	0.000643	CcSEcCtD
Capecitabine—Infection—Betamethasone—ankylosing spondylitis	0.000305	0.000643	CcSEcCtD
Capecitabine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000304	0.000641	CcSEcCtD
Capecitabine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000304	0.00064	CcSEcCtD
Capecitabine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000303	0.000639	CcSEcCtD
Capecitabine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000303	0.000639	CcSEcCtD
Capecitabine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000303	0.000639	CcSEcCtD
Capecitabine—Anaemia—Prednisone—ankylosing spondylitis	0.000303	0.000638	CcSEcCtD
Capecitabine—Shock—Dexamethasone—ankylosing spondylitis	0.000302	0.000637	CcSEcCtD
Capecitabine—Shock—Betamethasone—ankylosing spondylitis	0.000302	0.000637	CcSEcCtD
Capecitabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000302	0.000636	CcSEcCtD
Capecitabine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000301	0.000634	CcSEcCtD
Capecitabine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000301	0.000634	CcSEcCtD
Capecitabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000301	0.000633	CcSEcCtD
Capecitabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000301	0.000633	CcSEcCtD
Capecitabine—Tachycardia—Betamethasone—ankylosing spondylitis	0.0003	0.000631	CcSEcCtD
Capecitabine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.0003	0.000631	CcSEcCtD
Capecitabine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000298	0.000628	CcSEcCtD
Capecitabine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000297	0.000627	CcSEcCtD
Capecitabine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000297	0.000626	CcSEcCtD
Capecitabine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000297	0.000625	CcSEcCtD
Capecitabine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000297	0.000625	CcSEcCtD
Capecitabine—Malaise—Prednisone—ankylosing spondylitis	0.000296	0.000623	CcSEcCtD
Capecitabine—Vertigo—Prednisone—ankylosing spondylitis	0.000294	0.00062	CcSEcCtD
Capecitabine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000294	0.000619	CcSEcCtD
Capecitabine—Syncope—Prednisone—ankylosing spondylitis	0.000294	0.000619	CcSEcCtD
Capecitabine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000293	0.000618	CcSEcCtD
Capecitabine—Anorexia—Betamethasone—ankylosing spondylitis	0.000293	0.000617	CcSEcCtD
Capecitabine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000293	0.000617	CcSEcCtD
Capecitabine—Urticaria—Prednisolone—ankylosing spondylitis	0.000292	0.000616	CcSEcCtD
Capecitabine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000292	0.000615	CcSEcCtD
Capecitabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000292	0.000615	CcSEcCtD
Capecitabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000291	0.000613	CcSEcCtD
Capecitabine—Pain—Triamcinolone—ankylosing spondylitis	0.000289	0.00061	CcSEcCtD
Capecitabine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000288	0.000607	CcSEcCtD
Capecitabine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000287	0.000605	CcSEcCtD
Capecitabine—Hypotension—Betamethasone—ankylosing spondylitis	0.000287	0.000605	CcSEcCtD
Capecitabine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000285	0.000601	CcSEcCtD
Capecitabine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000284	0.000599	CcSEcCtD
Capecitabine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000284	0.000597	CcSEcCtD
Capecitabine—Hypertension—Prednisone—ankylosing spondylitis	0.000283	0.000596	CcSEcCtD
Capecitabine—Chills—Methotrexate—ankylosing spondylitis	0.000282	0.000595	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00028	0.000589	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00028	0.000589	CcSEcCtD
Capecitabine—Myalgia—Prednisone—ankylosing spondylitis	0.000279	0.000588	CcSEcCtD
Capecitabine—Arthralgia—Prednisone—ankylosing spondylitis	0.000279	0.000588	CcSEcCtD
Capecitabine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000279	0.000588	CcSEcCtD
Capecitabine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000278	0.000586	CcSEcCtD
Capecitabine—Anxiety—Prednisone—ankylosing spondylitis	0.000278	0.000586	CcSEcCtD
Capecitabine—Alopecia—Methotrexate—ankylosing spondylitis	0.000278	0.000586	CcSEcCtD
Capecitabine—Insomnia—Betamethasone—ankylosing spondylitis	0.000278	0.000585	CcSEcCtD
Capecitabine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000278	0.000585	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000277	0.000584	CcSEcCtD
Capecitabine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000276	0.000582	CcSEcCtD
Capecitabine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000276	0.000581	CcSEcCtD
Capecitabine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000276	0.000581	CcSEcCtD
Capecitabine—Discomfort—Prednisone—ankylosing spondylitis	0.000276	0.000581	CcSEcCtD
Capecitabine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000276	0.000581	CcSEcCtD
Capecitabine—Erythema—Methotrexate—ankylosing spondylitis	0.000274	0.000577	CcSEcCtD
Capecitabine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000274	0.000577	CcSEcCtD
Capecitabine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000271	0.000571	CcSEcCtD
Capecitabine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00027	0.00057	CcSEcCtD
Capecitabine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00027	0.00057	CcSEcCtD
Capecitabine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000269	0.000566	CcSEcCtD
Capecitabine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000268	0.000565	CcSEcCtD
Capecitabine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000268	0.000565	CcSEcCtD
Capecitabine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000268	0.000564	CcSEcCtD
Capecitabine—Oedema—Prednisone—ankylosing spondylitis	0.000267	0.000563	CcSEcCtD
Capecitabine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000267	0.000562	CcSEcCtD
Capecitabine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000267	0.000562	CcSEcCtD
Capecitabine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000267	0.000562	CcSEcCtD
Capecitabine—Infection—Prednisone—ankylosing spondylitis	0.000266	0.00056	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000265	0.000559	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000265	0.000559	CcSEcCtD
Capecitabine—Back pain—Methotrexate—ankylosing spondylitis	0.000265	0.000558	CcSEcCtD
Capecitabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000265	0.000558	CcSEcCtD
Capecitabine—Fatigue—Betamethasone—ankylosing spondylitis	0.000265	0.000558	CcSEcCtD
Capecitabine—Shock—Prednisone—ankylosing spondylitis	0.000263	0.000554	CcSEcCtD
Capecitabine—Pain—Betamethasone—ankylosing spondylitis	0.000263	0.000553	CcSEcCtD
Capecitabine—Pain—Dexamethasone—ankylosing spondylitis	0.000263	0.000553	CcSEcCtD
Capecitabine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000262	0.000553	CcSEcCtD
Capecitabine—Tachycardia—Prednisone—ankylosing spondylitis	0.000261	0.00055	CcSEcCtD
Capecitabine—Skin disorder—Prednisone—ankylosing spondylitis	0.00026	0.000547	CcSEcCtD
Capecitabine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000259	0.000545	CcSEcCtD
Capecitabine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000258	0.000544	CcSEcCtD
Capecitabine—Anorexia—Prednisone—ankylosing spondylitis	0.000255	0.000537	CcSEcCtD
Capecitabine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000254	0.000535	CcSEcCtD
Capecitabine—Anaemia—Methotrexate—ankylosing spondylitis	0.000253	0.000533	CcSEcCtD
Capecitabine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000253	0.000533	CcSEcCtD
Capecitabine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000253	0.000533	CcSEcCtD
Capecitabine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000251	0.000529	CcSEcCtD
Capecitabine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000251	0.000529	CcSEcCtD
Capecitabine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000249	0.000525	CcSEcCtD
Capecitabine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000249	0.000524	CcSEcCtD
Capecitabine—Malaise—Methotrexate—ankylosing spondylitis	0.000247	0.00052	CcSEcCtD
Capecitabine—Vertigo—Methotrexate—ankylosing spondylitis	0.000246	0.000518	CcSEcCtD
Capecitabine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000245	0.000516	CcSEcCtD
Capecitabine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000244	0.000514	CcSEcCtD
Capecitabine—Urticaria—Betamethasone—ankylosing spondylitis	0.000244	0.000514	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000244	0.000513	CcSEcCtD
Capecitabine—Dizziness—Prednisolone—ankylosing spondylitis	0.000243	0.000513	CcSEcCtD
Capecitabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000243	0.000512	CcSEcCtD
Capecitabine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000243	0.000511	CcSEcCtD
Capecitabine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000243	0.000511	CcSEcCtD
Capecitabine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000243	0.000511	CcSEcCtD
Capecitabine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000243	0.000511	CcSEcCtD
Capecitabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000242	0.00051	CcSEcCtD
Capecitabine—Insomnia—Prednisone—ankylosing spondylitis	0.000242	0.00051	CcSEcCtD
Capecitabine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00024	0.000506	CcSEcCtD
Capecitabine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000239	0.000504	CcSEcCtD
Capecitabine—Cough—Methotrexate—ankylosing spondylitis	0.000239	0.000503	CcSEcCtD
Capecitabine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000239	0.000503	CcSEcCtD
Capecitabine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000235	0.000496	CcSEcCtD
Capecitabine—Myalgia—Methotrexate—ankylosing spondylitis	0.000233	0.000491	CcSEcCtD
Capecitabine—Chest pain—Methotrexate—ankylosing spondylitis	0.000233	0.000491	CcSEcCtD
Capecitabine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000233	0.000491	CcSEcCtD
Capecitabine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000232	0.00049	CcSEcCtD
Capecitabine—Rash—Prednisolone—ankylosing spondylitis	0.000232	0.000489	CcSEcCtD
Capecitabine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000232	0.000488	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000232	0.000488	CcSEcCtD
Capecitabine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000231	0.000487	CcSEcCtD
Capecitabine—Fatigue—Prednisone—ankylosing spondylitis	0.000231	0.000486	CcSEcCtD
Capecitabine—Headache—Prednisolone—ankylosing spondylitis	0.000231	0.000486	CcSEcCtD
Capecitabine—Discomfort—Methotrexate—ankylosing spondylitis	0.00023	0.000485	CcSEcCtD
Capecitabine—Constipation—Prednisone—ankylosing spondylitis	0.000229	0.000482	CcSEcCtD
Capecitabine—Confusional state—Methotrexate—ankylosing spondylitis	0.000225	0.000475	CcSEcCtD
Capecitabine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000224	0.000472	CcSEcCtD
Capecitabine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000223	0.00047	CcSEcCtD
Capecitabine—Infection—Methotrexate—ankylosing spondylitis	0.000222	0.000468	CcSEcCtD
Capecitabine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00022	0.000464	CcSEcCtD
Capecitabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00022	0.000464	CcSEcCtD
Capecitabine—Asthenia—Betamethasone—ankylosing spondylitis	0.00022	0.000464	CcSEcCtD
Capecitabine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000219	0.000462	CcSEcCtD
Capecitabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000219	0.000461	CcSEcCtD
Capecitabine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000219	0.000461	CcSEcCtD
Capecitabine—Nausea—Prednisolone—ankylosing spondylitis	0.000219	0.000461	CcSEcCtD
Capecitabine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000217	0.000458	CcSEcCtD
Capecitabine—Pruritus—Betamethasone—ankylosing spondylitis	0.000217	0.000458	CcSEcCtD
Capecitabine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000217	0.000457	CcSEcCtD
Capecitabine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000216	0.000455	CcSEcCtD
Capecitabine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000215	0.000453	CcSEcCtD
Capecitabine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000215	0.000452	CcSEcCtD
Capecitabine—Rash—Triamcinolone—ankylosing spondylitis	0.000213	0.00045	CcSEcCtD
Capecitabine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000213	0.000449	CcSEcCtD
Capecitabine—Anorexia—Methotrexate—ankylosing spondylitis	0.000213	0.000449	CcSEcCtD
Capecitabine—Rash—Methylprednisolone—ankylosing spondylitis	0.000213	0.000449	CcSEcCtD
Capecitabine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000213	0.000448	CcSEcCtD
Capecitabine—Urticaria—Prednisone—ankylosing spondylitis	0.000212	0.000448	CcSEcCtD
Capecitabine—Headache—Triamcinolone—ankylosing spondylitis	0.000212	0.000447	CcSEcCtD
Capecitabine—Headache—Methylprednisolone—ankylosing spondylitis	0.000212	0.000446	CcSEcCtD
Capecitabine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000211	0.000445	CcSEcCtD
Capecitabine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000211	0.000445	CcSEcCtD
Capecitabine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00021	0.000443	CcSEcCtD
Capecitabine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00021	0.000443	CcSEcCtD
Capecitabine—Hypotension—Methotrexate—ankylosing spondylitis	0.000209	0.00044	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000204	0.000429	CcSEcCtD
Capecitabine—Dizziness—Betamethasone—ankylosing spondylitis	0.000203	0.000428	CcSEcCtD
Capecitabine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000203	0.000428	CcSEcCtD
Capecitabine—Insomnia—Methotrexate—ankylosing spondylitis	0.000202	0.000426	CcSEcCtD
Capecitabine—Nausea—Triamcinolone—ankylosing spondylitis	0.000201	0.000424	CcSEcCtD
Capecitabine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000201	0.000423	CcSEcCtD
Capecitabine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000201	0.000423	CcSEcCtD
Capecitabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000199	0.00042	CcSEcCtD
Capecitabine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000197	0.000415	CcSEcCtD
Capecitabine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000197	0.000415	CcSEcCtD
Capecitabine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000195	0.000411	CcSEcCtD
Capecitabine—Vomiting—Betamethasone—ankylosing spondylitis	0.000195	0.000411	CcSEcCtD
Capecitabine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000194	0.000409	CcSEcCtD
Capecitabine—Rash—Betamethasone—ankylosing spondylitis	0.000194	0.000408	CcSEcCtD
Capecitabine—Rash—Dexamethasone—ankylosing spondylitis	0.000194	0.000408	CcSEcCtD
Capecitabine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000193	0.000408	CcSEcCtD
Capecitabine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000193	0.000408	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000193	0.000407	CcSEcCtD
Capecitabine—Fatigue—Methotrexate—ankylosing spondylitis	0.000193	0.000406	CcSEcCtD
Capecitabine—Headache—Dexamethasone—ankylosing spondylitis	0.000192	0.000405	CcSEcCtD
Capecitabine—Headache—Betamethasone—ankylosing spondylitis	0.000192	0.000405	CcSEcCtD
Capecitabine—Asthenia—Prednisone—ankylosing spondylitis	0.000192	0.000404	CcSEcCtD
Capecitabine—Pain—Methotrexate—ankylosing spondylitis	0.000191	0.000403	CcSEcCtD
Capecitabine—Pruritus—Prednisone—ankylosing spondylitis	0.000189	0.000399	CcSEcCtD
Capecitabine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000184	0.000388	CcSEcCtD
Capecitabine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000183	0.000386	CcSEcCtD
Capecitabine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000183	0.000385	CcSEcCtD
Capecitabine—Nausea—Betamethasone—ankylosing spondylitis	0.000182	0.000384	CcSEcCtD
Capecitabine—Nausea—Dexamethasone—ankylosing spondylitis	0.000182	0.000384	CcSEcCtD
Capecitabine—Urticaria—Methotrexate—ankylosing spondylitis	0.000178	0.000374	CcSEcCtD
Capecitabine—Dizziness—Prednisone—ankylosing spondylitis	0.000177	0.000373	CcSEcCtD
Capecitabine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000177	0.000372	CcSEcCtD
Capecitabine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000177	0.000372	CcSEcCtD
Capecitabine—Vomiting—Prednisone—ankylosing spondylitis	0.00017	0.000358	CcSEcCtD
Capecitabine—Rash—Prednisone—ankylosing spondylitis	0.000169	0.000355	CcSEcCtD
Capecitabine—Dermatitis—Prednisone—ankylosing spondylitis	0.000168	0.000355	CcSEcCtD
Capecitabine—Headache—Prednisone—ankylosing spondylitis	0.000168	0.000353	CcSEcCtD
Capecitabine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000165	0.000347	CcSEcCtD
Capecitabine—Asthenia—Methotrexate—ankylosing spondylitis	0.00016	0.000338	CcSEcCtD
Capecitabine—Nausea—Prednisone—ankylosing spondylitis	0.000159	0.000335	CcSEcCtD
Capecitabine—Pruritus—Methotrexate—ankylosing spondylitis	0.000158	0.000333	CcSEcCtD
Capecitabine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000153	0.000322	CcSEcCtD
Capecitabine—Dizziness—Methotrexate—ankylosing spondylitis	0.000148	0.000311	CcSEcCtD
Capecitabine—Vomiting—Methotrexate—ankylosing spondylitis	0.000142	0.000299	CcSEcCtD
Capecitabine—Rash—Methotrexate—ankylosing spondylitis	0.000141	0.000297	CcSEcCtD
Capecitabine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000141	0.000297	CcSEcCtD
Capecitabine—Headache—Methotrexate—ankylosing spondylitis	0.00014	0.000295	CcSEcCtD
Capecitabine—Nausea—Methotrexate—ankylosing spondylitis	0.000133	0.00028	CcSEcCtD
